Medicxi Ventures 1 Overview
Medicxi Ventures 1 General Information
Description
Medicxi Ventures 1 is a 2016 vintage venture capital fund managed by Medicxi. The fund is located in London, United Kingdom. The fund targets pharmaceuticals, biotechnology, life sciences and oncology sectors.
Contact Information
Fund Manager's Location
- 25 Great Pulteney Street
- London W1F 9LT
- England, United Kingdom
Medicxi Ventures 1 Investments (11)
Medicxi Ventures 1 has made a total of 11 investments. Its most recent deal was a with ViceBio. The deal was made on 13-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ViceBio | 13-Apr-2021 | Drug Discovery | Stealth | |||
| Morphogen-IX | 18-Dec-2018 | Drug Discovery | Generating Revenue | |||
| Z Factor | 03-May-2017 | Drug Discovery | Startup | |||
| SuperX. | 09-Feb-2017 | Drug Discovery | Startup | |||
| ApcinteX | 07-Dec-2016 | Drug Discovery | Generating Revenue | |||
| Mavalon Therapeutics | 18-Oct-2016 | Drug Discovery | Startup | |||
| Kymo Therapeutics | 19-Sep-2016 | Biotechnology | Startup | |||
| Palladio Biosciences | 26-Jul-2016 | Biotechnology | Clinical Trials - Phase 1 | |||
| Capella BioScience | 03-Apr-2016 | Early Stage VC (Series A) | Drug Discovery | Pre-Clinical Trials | ||
| Gadeta | 29-Mar-2016 | Early Stage VC (Series A) | Biotechnology | Startup |
Medicxi Ventures 1 Investment Strategy
Investments by Industry
Investments by Deal Type
Medicxi Ventures 1 Limited Partners (4)
GSK is one of Medicxi Ventures 1’s 4 limited partners. Its latest Original was on 02-Feb-2016.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| GSK | Current | 02-Feb-2016 | Original | ||
| Johnson & Johnson Innovation - JJDC | Current | 02-Feb-2016 | Original | ||
| Liberty Mutual Retirement Benefit Plan | Current | 02-Feb-2016 | Original | ||
| Massachusetts Pension Reserves Investment Trust | Public Pension Fund | Current | 02-Feb-2016 | Original |
Medicxi Ventures 1 Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Medicxi Ventures 1 Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Medicxi Ventures 1 Benchmark (37)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| NEO Investments II | |||||
| GR Capital Fund I | |||||
| PROfounders Capital II | |||||
| Abingworth Clinical Co-Development Fund | |||||
| Techstars London 2016 | |||||
| Partners Capital Condor Fund IX | |||||
| AddVenture V | |||||
| ALS Investment Fund I | |||||
| Spring Partners Base I | |||||
| TempoCap Fund I |
Medicxi Ventures 1 FAQs
-
What is Medicxi Ventures 1?
Medicxi Ventures 1 is a 2016 vintage venture capital fund managed by Medicxi.
-
Who manages Medicxi Ventures 1?
Medicxi Ventures 1 is managed by Medicxi.
-
Where is Medicxi Ventures 1 domiciled?
Medicxi Ventures 1 is domiciled in United Kingdom: Jersey.
-
What is Medicxi Ventures 1's size?
Medicxi Ventures 1 has a size of .
-
What type of fund is Medicxi Ventures 1?
The fund type of Medicxi Ventures 1 is Venture.
-
What is the status of Medicxi Ventures 1?
Medicxi Ventures 1 is closed.
-
What has Medicxi Ventures 1 invested in?
Medicxi Ventures 1 has made numerous investments in companies like ViceBio, Morphogen-IX, and Z Factor within the Drug Discovery industry.
-
What has Medicxi Ventures 1 invested in recently?
Medicxi Ventures 1's latest investment was on 13-Apr-2021 in ViceBio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
